These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1698362)

  • 1. HRF20, a membrane inhibitor of complement attack, does not protect cells from the cytotoxic reaction by lymphokine activated killer cells.
    Okada H; Okada N; Hideshima T
    Biochem Biophys Res Commun; 1990 Sep; 171(2):717-21. PubMed ID: 1698362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: their role in sensitivity to human serum-mediated lysis.
    Kuraya M; Yefenof E; Klein G; Klein E
    Eur J Immunol; 1992 Jul; 22(7):1871-6. PubMed ID: 1378022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells.
    Lee RK; Spielman J; Zhao DY; Olsen KJ; Podack ER
    J Immunol; 1996 Sep; 157(5):1919-25. PubMed ID: 8757310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete deficiency of 20 KDa homologous restriction factor (HRF20) and restoration with purified HRF20.
    Okada N; Harada R; Taguchi R; Okada H
    Biochem Biophys Res Commun; 1989 Oct; 164(1):468-73. PubMed ID: 2803313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species-specific restriction of complement by HRF20 (CD59) generated by cDNA transfection.
    Takizawa H; Takahashi K; Murakami T; Okada N; Okada H
    Eur J Immunol; 1992 Jul; 22(7):1943-6. PubMed ID: 1378024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of HRF20, a regulatory molecule of complement activation, on peripheral blood mononuclear cells.
    Hideshima T; Okada N; Okada H
    Immunology; 1990 Mar; 69(3):396-401. PubMed ID: 1690178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of protectin (CD59) in human melanoma and its functional role in cell- and complement-mediated cytotoxicity.
    Brasoveanu LI; Altomonte M; Gloghini A; Fonsatti E; Coral S; Gasparollo A; Montagner R; Cattarossi I; Simonelli C; Cattelan A
    Int J Cancer; 1995 May; 61(4):548-56. PubMed ID: 7538980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells.
    Brandau S; Suttmann H; Riemensberger J; Seitzer U; Arnold J; Durek C; Jocham D; Flad HD; Böhle A
    Clin Cancer Res; 2000 Sep; 6(9):3729-38. PubMed ID: 10999767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human complement-dependent cell lysis by bovine aortic endothelial cells transfected with membrane-bound complement-regulatory factor (DAF and HRF20) gene using a retroviral vector.
    Hayashi S; Isobe K; Emi N; Yokoyama I; Okada H; Nakashima I; Takagi H
    Eur Surg Res; 1996; 28(6):440-6. PubMed ID: 8954321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-12 up-regulates perforin- and Fas-mediated lymphokine-activated killer activity by intestinal intraepithelial lymphocytes.
    Ebert EC
    Clin Exp Immunol; 2004 Nov; 138(2):259-65. PubMed ID: 15498035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytolysis of human dendritic cells by autologous lymphokine-activated killer cells: participation of both T cells and NK cells in the killing.
    Parajuli P; Nishioka Y; Nishimura N; Singh SM; Hanibuchi M; Nokihara H; Yanagawa H; Sone S
    J Leukoc Biol; 1999 Jun; 65(6):764-70. PubMed ID: 10380897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human tumor cell line resistance to chemotherapeutic agents does not predict resistance to natural killer or lymphokine-activated killer cell-mediated cytolysis.
    Harker WG; Tom C; McGregor JR; Slade L; Samlowski WE
    Cancer Res; 1990 Sep; 50(18):5931-6. PubMed ID: 1975512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue distribution of HRF20, a novel factor preventing the membrane attack of homologous complement, and its predominant expression on endothelial cells in vivo.
    Nose M; Katoh M; Okada N; Kyogoku M; Okada H
    Immunology; 1990 Jun; 70(2):145-9. PubMed ID: 1695609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of target molecule of murine lymphokine-activated killer (LAK) cells and the clones.
    Hashimoto Y; Kato K; Sato N; Yagi H; Yagita H; Nishimura T
    Princess Takamatsu Symp; 1988; 19():315-22. PubMed ID: 3077625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of phorbol ester-sensitive protein kinase C isoforms in lymphokine-activated killer cell-mediated cytotoxicity: dissociation between perforin-dependent and Fas-dependent cytotoxicity.
    Ohmi Y; Ohta A; Sasakura Y; Sato N; Yahata T; Santa K; Habu S; Nishimura T
    Biochem Biophys Res Commun; 1997 Jun; 235(3):461-4. PubMed ID: 9207176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The over-expression of P-glycoprotein in K-562 and DAUDI cells, is associated with a high susceptibility to NK and LAK cells.
    Dupuis ML; Ramoni C; Yassen A; Samoggia P; Tombesi M; Caserta M; Cianfriglia M
    J Biol Regul Homeost Agents; 1991; 5(4):137-41. PubMed ID: 1687102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid.
    Barton DP; Blanchard DK; Duan C; Roberts WS; Cavanagh D; DeCesare S; Djeu JY
    J Soc Gynecol Investig; 1995; 2(6):762-71. PubMed ID: 9420887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human protectin (CD59), an 18-20-kD homologous complement restriction factor, does not restrict perforin-mediated lysis.
    Meri S; Morgan BP; Wing M; Jones J; Davies A; Podack E; Lachmann PJ
    J Exp Med; 1990 Jul; 172(1):367-70. PubMed ID: 1694224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphokine activated killer cells from umbilical cord blood show higher antitumor effect against anaplastic astrocytoma cell line (U87) and medulloblastoma cell line (TE671) than lymphokine activated killer cells from peripheral blood.
    Kang SG; Ryu CH; Jeun SS; Park CK; Shin HJ; Kim JH; Kim MC; Kang JK
    Childs Nerv Syst; 2004 Mar; 20(3):154-62. PubMed ID: 14968374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid loss of perforin and serine protease RNA in cytotoxic lymphocytes exposed to sensitive targets.
    Bajpai A; Kwon BS; Brahmi Z
    Immunology; 1991 Oct; 74(2):258-63. PubMed ID: 1721042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.